KEGG   DRUG: Remestemcel-L
Entry
D09719                      Drug                                   
Name
Remestemcel-L (USAN);
Remestemcel-L-rknd;
Ryoncil (TN);
Prochymal (TN)
Product
RYONCIL (Mesoblast)
Remark
Product: D09719<US>
Efficacy
Anti-inflammatory, Immunomodulator, Tissue protectant
  Disease
Acute graft versus host disease (steroid-refractory) [DS:H00084]
  Type
Cellular therapy product
Brite
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D09719
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D09719
Other DBs
PubChem: 124490459
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system